Jefferies Reiterates Buy and PT of $77 on Catalyst Health Solutions

Jefferies reiterated its Buy rating on Catalyst Health Solutions CHSI. At the same time, the rating agency left its price target on the company's stock unchanged at $77. On Tuesday, CHSI lost 2.99% of its value to finish the day at $61.94. Its shares rebounded in today's pre-market trading, rising 3.08% to stand around $63.85.